INTRODUCTION
============

Brassinosteroids (BRs) are highly potent growth-promoting sterol derivatives. BR-deficient and BR-insensitive mutants in *Arabidopsis*, pea, tomato, barley and rice show dwarfism ([@b1]). The growth-promoting effect of BR was assigned to changes in transcript levels of genes involved in cell wall modifications such as xyloglucan endotransglucosylase/hydrolases and expansins. Other BR-regulated genes point to further mechanisms contributing to growth. BR apparently coordinates diverse processes, partly through interactions with other phytohormones. Enhanced resistance of BR-treated plants to temperature, salt, water, phytopathogens and other environmental stresses has been reported ([@b2]--[@b4]). However, underlying molecular mechanisms are unknown. The growth effects of exogenous BR are light-dependent. *Arabidopsis* mutants such as *det2*, *cpd* and *bri1* display short hypocotyls, opened cotyledons, and emergence of primary leaves in darkness. These findings suggest a cross-talk between photomorphogenesis and steroid signal transduction ([@b5]).

In several studies, BR-responsive gene expression in *Arabidopsis* was analysed ([@b6]--[@b10]). Comparisons of expression profiling experiments revealed that the majority of identified genes do not show consistent BR-dependent expression in different genotypes, environmental conditions, developmental stages and tissues, and upon BR-treatment ([@b11],[@b12]). Thus, gene expression patterns are conditional, and the identified genes probably present only a subset of genes involved in BR-responses. Another reason for the incomplete discovery of genomic effects is the hitherto limited number of experiments, as gene expression varies even under highly controlled conditions. Many genes fail to meet the stringent selection criteria routinely applied in expression profiling experiments.

Cross-experiment co-response analysis provides an alternative approach which is based on the assumption that common transcriptional control of genes should be reflected in synchronous changes in transcript levels. Co-response analysis describes common changes of transcript levels among gene pairs. Publicly available expression profiles represent a rich resource for cross-experiment investigations. CSB.DB \[<http://csbdb.mpimp-golm.mpg.de/> ([@b13])\] provides access to co-response analysis based on numerous independent expression profiling experiments.

Here, we describe a strategy to identify BR-associated genes using the *BRI1* and *BAK1* genes. In the following, these anchors for subsequent co-response analyses will be termed 'guide genes' and correlated genes will be termed 'associated genes'. We demonstrate means of *in silico* cross-checking and confirmation using the publicly available Affymetrix expression profiles provided by the AtGenExpress consortium. In addition, 44 cell wall and growth-related genes were selected for wet-lab experimental validation and subsequent real-time RT--PCR.

MATERIALS AND METHODS
=====================

Co-response analyses
--------------------

Transcript co-responses were retrieved from CSB.DB \[a comprehensive systems-biology database; <http://csbdb.mpimp-golm.mpg.de> ([@b13])\] for the data matrices nasc0271, nasc0272 and nasc0273. A total of 123 expression profiles from 22 experiments were obtained from NASCarrays \[<http://affymetrix.arabidopsis.info/> ([@b14])\] and used for generation of the data matrices \[supplement.XLS sheet 11 (nasc profiles)\]. All profiles were based on 22k Affymetrix ATH1 GeneChips (Affymetrix, La Jolla, CA). The number of Present and Marginal calls (according to the MAS 5.0 Detection algorithm) was calculated for each profile. In most cases, 2 or 3 profiles per experiment with the highest numbers of Present and Marginal calls were selected for nasc0271. Nasc0271 covers the expression of 9694 genes that were well measured in at least 85% of the underlying expression profiles. The nasc0272 and nasc0273 matrices were generated from profiles which ranked 2nd and 3rd according to the numbers of Present and Marginal calls. The nasc0272 matrix was based on 51 profiles and represents 8927 genes. The nasc0273 matrix was based on 49 experiments and represents 8691 genes. Correlations were based on non-parametric Spearman\'s rank-order correlation (*r*~s~). Positive transcriptional co-responses with an uncorrected probability for multiple comparisons of \<0.01 (99%) and a power of test of \>0.7 (70%) were retrieved. From the initial result with the nasc0271 matrix (which covers 301 associated genes), 135 genes were selected and used for statistical in-depth analyses. To test for influence of individual or small subsets of underlying expression profiles, transcriptional co-responses were confirmed by bootstrap analyses. Bootstrap spearman correlation, probability, confidence interval and power of test were re-computed using the statistical software environment R (<http://www.r-project.org>) by non-parametric bootstrap analyses with 2000 numbers of bootstrap samples ([@b15]) on the log base 2 and range normalized signal intensities.

Distribution of functional categories
-------------------------------------

Assignments of genes into bins were taken from the MapMan software ([@b16]). Obtained assignments were slightly modified for bins that cover few genes. Merging of bins is illustrated in Table SI (Supplementary information). Genes without assignment or with unclear classification were termed 'unclassified'. The relative impact (ri) of a gene with multiple assignments (*n*~assign~) onto each category was defined as ri = 1/*n*~assign~. The distribution of retrieved genes into functional categories was computed by adding-up the relative assignment coefficient for each gene per category.

Plant material and growth conditions for real-time RT--PCR
----------------------------------------------------------

Two growth conditions were applied. *Arabidopsis thaliana* cv. C24 (wild-type), *dwf1--6* (*cbb1*), *cbb2* and *cbb3* mutants were grown in half-concentrated MS medium supplemented with 1% sucrose and solidified with 0.7% agar under a 16 h day (140 μE, 22°C)/8 h (22°C) night regime. Plants were harvested 14 or 19 days after sowing. Roots were discarded. Alternatively, *Arabidopsis thaliana* cv. C24, *dwf1--6* and *CPD*-antisense plants were grown in soil under long day conditions (16 h fluorescent light, 180 μE, 20°C, 70% relative humidity/8 h dark, 16°C and 75% relative humidity). Aerial organs were harvested 28 days after sowing.

Real-time RT--PCR analysis
--------------------------

Total RNA was isolated using the Invisorb Spin Plant RNA kit (Invitek, Berlin, Germany). One microgram of total RNA was reverse-transcribed with Superscript II reverse transcriptase (Invitrogen) in a reaction volume of 28.5 μl to generate first-strand cDNA. Real-time RT--PCR was performed with 1 μl of the 1:3.5 diluted first-strand cDNA reaction and the SYBR Green reagent (Applied Biosystems, Foster City, CA) in a 25 μl volume. Primer sequences are given in [Table 1](#tbl1){ref-type="table"}. Data were normalized to the *eIF1a* gene (At5g60390) and then compared according to the formula (considering as example the *KCS1* gene): $$nC_{\text{T}} = C_{\text{T\ KCS}1} - C_{\text{T\ eIF}1\text{a}}$$ $$\Delta C_{T} = \text{signal\ log\ ratio} = nC_{\text{T\ mutant}} - nC_{\text{T\ WT}}$$ Amplification efficiency (*E*) was checked for all primer pairs. Briefly, *E*-values were derived from the log slope of fluorescence versus cycle number curve for a particular primer pair, using the Equation (1 + *E*) = 10^slope^. *E*-values for all primer pairs are summarized in [Table 1](#tbl1){ref-type="table"} and used to calculate normalized fold change values, using the Equation (1 + *E*)^ΔCT^. Control experiments showed that use of different control genes \[either *eIF1*α or *eIF4A1* (At3g13920, primers: ACAATGTGGTTGTCGAAGAGCTG and GCAGAGCAAACACAGCAACAGAA)\] did not bias results.

Analysis of Affymetrix expression profiles
------------------------------------------

Normalization and expression analysis were performed with the MAS 5.0 and GCOS software (Affymetrix). Output of all experiments was multiplied by a scaling factor to adjust its average intensity to a target intensity of 100. Results of Absolute and Comparison expression analysis were imported into MS Access2003 and screened for significant changes. The Detection algorithm calculates detection *p*-values and assigns Present, Marginal or Absent calls. Standard parameters were applied to remove genes with Absent and Marginal calls. Induced genes were expected to be Present in experiments representing higher phytohormone levels ('experimental' profiles). Repressed genes were expected to be Present in experiments representing lower phytohormone levels ('baseline' profiles). Simultaneously, Affymetrix Change and Signal Log Ratio algorithms were used in order to identify changes with high reliability. The Change algorithm is based on Wilcoxon\'s signed rank test and produces a final change *p*-value. This *p*-value ranges from 0.0 to 1.0. The signal log ratio estimates the magnitude and direction of change of a transcript. Significant increases of transcript levels in comparisons of two profiles are indicated by change *p*-values of \<0.01 and signal log ratios of ≥0.8. Significant decreases are indicated by change *p*-values of \>0.99 and signal log ratios of ≤−0.8. Interchanging 'experimental' and 'baseline' profiles mirrors results. Change *p*-values of \<0.01 and signal log ratios of ≥0.8 become \>0.99 and ≤−0.8, respectively (for details see [www.affymetrix.com](www.affymetrix.com)).

[Table 2](#tbl2){ref-type="table"} specifies AtGenExpress CEL files used for this study. Plant material was grown in liquid MS medium for 7 days at 23°C prior to the BL-, CS-, BRZ-, GA- and PAC-treatments. Two additional profiles were used \[7 h EBL and control treatment of wild-type (Col-0) plants grown in half-concentrated MS medium supplemented with 1% sucrose and solidified with 0.7% agar\] ([@b17]).

RESULTS
=======

Transcript co-response analysis: a novel approach to identify BR-related genes
------------------------------------------------------------------------------

Central part of CSB.DB is a set of co-response databases (CoR.DBs) which are based on publicly available transcript profiles. The basic assumption is that common transcriptional control of genes is accompanied by synchronous changes of transcript levels. Scanning for best co-responses among changing transcript levels allows the deduction of hypotheses about common regulation of genes ([@b18]). We propose a general strategy to exploit CSB.DB. The strategy is illustrated in [Figure 1](#fig1){ref-type="fig"}. The biological question determines the choice of the type of data matrix. Complex data matrices identify genes which are 'constitutively' associated with the guide genes. Specific matrices (e.g. representing certain tissues or stress conditions) identify genes within a specific context. After the selection of a suitable data matrix, useful guide genes have to be identified. The expression pattern and function determine the suitability of guide genes. Therefore, biological knowledge is required. The guide genes are used to screen for genes which show similar expression patterns in the profiles underlying a data matrix. Statistical methods and experiments allow testing of the identified genes. In the following section, the strategy is demonstrated using BR-related genes.

Assembly and selection of data matrices
---------------------------------------

Complex data matrices can be assembled by selecting transcript profiles representing many different experimental conditions. Complex data matrices include different genotypes, environmental conditions and developmental stages. To identify BR-related genes, the complex nasc0271 database was used. The matrix comprised 51 expression profiles \[<http://csbdb.mpimp-golm.mpg.de/csbdb/home/matrices/ath_nasc0271.html>; supplement.XLS sheet 11 (nasc profiles)\] representing a wide range of experimental conditions with a minimal overlap of identical experiments. All expression profiles were normalized using the MAS 5.0 software. Transcript measurements were required to have high quality, i.e. a detection call of Marginal or Present (according to standard parameters of the MAS 5.0 Detection algorithm) in at least 85% of the experiments. Thus, the nasc0271 matrix contained only 9694 accessible genes. Two other complex matrices (nasc0272 and nasc0273) were established using additional expression profiles \[supplement.XLS sheet 11 (nasc profiles)\]. These matrices were used to test and confirm the results obtained with the nasc0271 matrix. The nasc0272 and nasc0273 matrices consisted of 51 and 49 expression profiles and represented 8927 and 8691 genes, respectively.

Selection of guide genes and identification of transcript co-responses
----------------------------------------------------------------------

Biological knowledge is required for the selection of useful guide genes. The screen for BR-related genes shows that different options emerge. Three different classes of genes could be used: either known BR-responsive genes or BR-biosynthesis genes, or genes involved in BR-signalling. Use of known BR-responsive genes for co-response analyses reveals further BR-responsive genes ([Table 3](#tbl3){ref-type="table"}; statistical parameters below). However, BR-responsive genes are also likely to be regulated by other factors, and the functional context is unclear. For example, several BR-regulated such as *BEE1*, *DRT100*, *IAA3*, *MSS3*, *SAUR-AC1*, *SAUR16* and *TCH4* are auxin-regulated ([@b9],[@b19]), and the use of these genes will result in the identification of further auxin-related genes.The use of BR-biosynthesis genes, such as *CPD*, *DWF4* and *CYP85A1*, should result in higher specificity. Transcript co-responses with the *CPD* gene recovered several known BR-regulated genes ([Table 3](#tbl3){ref-type="table"}). However, transcripts of other BR-biosynthesis genes were excluded from the data matrices because of quality concerns and thus could not be tested.Use of BR-signalling components presents a third alternative. BR responses depend on signalling components such as BRI1, BAK1, BIN2, BZR1 and BES1. BRI1 is an essential receptor component for BR-responses. BR-insensitivity of *bri1* mutants ([@b20]--[@b22]) indicates that major BR-responses depend on BRI1. BAK1 is a receptor-like kinase which forms a heterodimer with BRI1 ([@b23],[@b24]). BAK1 was identified independently by a yeast two-hybrid screen for BRI1-interacting proteins and as suppressor of a weak *bri1* allele. A null allele of *BAK1* results in reduced (but not abolished) sensitivity to BR ([@b23]). In the presence of BR, the BRI1 and BAK1 proteins initiate a phosphorylation cascade which regulates BR-responsive genes. Downstream components such as BZR1 and BES1 regulate subsets of BR-responsive genes ([@b10]). However, BZR1 and BES1 could mediate responses to other stimuli as well, because the complex phosphorylation cascade between the BRI1/BAK1 and BZR/BES1 proteins is likely to receive additional input signals and thereby modulate BR-responses. In fact, *BRI1* and *BAK1* identified more known BR-regulated genes in the matrices than other signalling components ([Table 3](#tbl3){ref-type="table"}). The BRI1 protein is the major BR-receptor component in *Arabidopsis*. However, *Arabidopsis* BRI1 may bind other ligands. For example, tomato BRI1 perceives both BR and the peptide hormone systemin ([@b25],[@b26]). Therefore, *BAK1* was included as a second guide gene. *BRI1* and *BAK1* showed variable and correlated transcript levels throughout the set of expression profiles ([Figure 2](#fig2){ref-type="fig"}). Thus, the requirements for subsequent intersection analysis were met. Transcript co-response calculations are based on changes in mRNA levels within the underlying expression profiles. Spearman\'s non-parametric rank correlation coefficient (*r*~s~), *p*-value and power were used to retrieve transcript co-responses. Exclusion criteria for the statistical parameters were *r*~s~ \> 0.35, *p* \< 0.01 and power \>0.7, respectively.

The *BRI1* gene was associated with 1179 genes in the nasc0271 matrix (see below). These transcript co-responses identified 11 of 23 known BR-induced genes present in the nasc0271 matrix \[[Table 3](#tbl3){ref-type="table"} and supplement.XLS sheet 8 (nasc0271)\]. We define this observation as a co-response recovery of 47.8% and a specificity of 0.9% (for definitions and calculations, see [Table 3](#tbl3){ref-type="table"}). A total of 720 genes showed co-responses with the *BAK1* gene. The test for co-responses with known BR-induced genes resulted in 47.8% recovery and 1.5% specificity \[[Table 3](#tbl3){ref-type="table"} and supplement.XLS sheet 8 (nasc0271)\].

The intersection gene query with *BRI1* and *BAK1* resulted in the identification of 301 co-responding genes. Public databases contained information that allowed functional categorization of \>50% of these genes \[supplement.XLS sheet 1 (301 genes); supplementary data (Figure S1 and Table SI)\]. In agreement with high correlation of *BRI1* and *BAK1* expression, 8 of 23 known BR-regulated genes were still present after intersection analysis in the nasc0271 matrix resulting in 34.8% recovery and 2.7% specificity ([Table 4](#tbl4){ref-type="table"}).

Two other data matrices were used for an intersection gene query with the *BRI1* and *BAK1* genes. Intersection gene queries with the nasc0272 and nasc0273 matrices resulted in the identification of 144 and 161 genes, respectively: 69% and 71% of these genes were also present in the *BRI1*/*BAK1* intersection of the nasc0271 matrix \[including several known BR-regulated genes; [Table 3](#tbl3){ref-type="table"} and supplement.XLS sheet 9 (nasc0272) and sheet 10 (nasc0273)\]. Therefore, the nasc0271, nasc0272 and nasc0273 data matrices produced similar results.

EVALUATION OF IDENTIFIED GENES
==============================

Statistical evaluation of co-responses
--------------------------------------

Non-parametric bootstrap analysis with 2000 bootstrap samples was exemplarily performed with 135 associated genes, which could be functionally classified (including *BRI1* and *BAK1*). The resulting Spearman correlation coefficients (*r*~s~), *p*-values and power values confirmed correlated behaviour of both the *BAK1* gene and the *BRI1* gene with the respective other 134 genes. A complete matrix of all gene correlations is provided \[supplement.XLS sheet 2 (Spearman rs), sheet 3 (*p*-value) and sheet 4 (power)\].

Affymetrix expression profiling experiments
-------------------------------------------

The *BRI1*/*BAK1* intersection gene query was expected to identify associated genes which we call 'BR-related' genes. The BR-related genes comprise different classes of genes, namely BR-responsive genes and genes which mirror the functional context of *BRI1* and *BAK1*.

Altered transcript levels in plants with altered BR-levels or altered BR-sensitivity confirm the BR-responsiveness of genes. Publicly available expression profiles were used for *in silico* cross-checking of the 301 associated genes identified with the nasc0271 matrix. AtGenExpress is a multinational coordinated effort to uncover the transcriptome of *Arabidopsis* (<http://www.uni-frankfurt.de/fb15/botanik/mcb/AFGN/atgenex.htm>). For this study, expression profiles established by Hideki Goda (Plant Science Center and Plant Functions Laboratory, RIKEN, Japan) and two own profiles ([@b17]) were used. Expression profiles were analyzed using the stringent settings of the statistical algorithms of the MAS5.0 and GCOS software (see Materials and Methods).

Thirty expression profiles of brassinolide (BL)-, 24-epibrassinolide (EBL)-, castasterone (CS)- or control-treated wild-type and BR-deficient *det2* plants were used for 15 comparisons. Results were screened for the overlap with the 301 associated genes: 55 genes showed stronger expression upon BR-treatment in at least two independent situations \[supplement.XLS sheet 6 (Affx results BRs, BRZ)\]; 14 genes including *BRI1* and a *BRI1* homolog (At1g72180) revealed weaker expression in at least two independent experiments. These up- or down-regulated genes did not show conflicting expression patterns (i.e. were not inversely regulated in other situations).

Exogenously applied BR strongly promotes growth. The observed transcript co-responses could be related to growth rather than to specific BR action. In this case, expression may be induced by other growth-promoting compounds such as GA. Therefore, 24 expression profiles of GA~3~- or control-treated wild-type and *ga1--5* plants were used for 12 comparisons. Genes with significantly altered transcript levels were compared with the 301 candidate genes. Only one gene showed stronger expression upon GA-treatment \[supplement.XLS sheet 7 (Affx results GA3, PAC)\].

Reduced BR-levels should result in weaker expression of BR-induced genes. Brassinazole (BRZ) is a specific BR biosynthesis inhibitor: 12 expression profiles of BRZ- or control-treated wild-type plants were used for 8 comparisons; 17 (of 301) genes showed reduced expression in the presence of BRZ in at least two independent situations \[supplement.XLS sheet 6 (Affx results BRs, BRZ)\]. In order to test the effects of reduced GA-levels, eight expression profiles of paclobutrazol (PAC)- or control-treated wild-type plants were used for four comparisons. Only two genes (of 301) showed weaker expression in presence of PAC \[supplement.XLS sheet 7 (Affx results GA3, PAC)\]. Thus, transcript levels of the identified genes were marginally affected by GA. This implies that the genes are not secondarily regulated by growth, and dissection of the genomic basis of BR-promoted growth is feasible.

Real-time RT--PCR analysis of growth-related genes
--------------------------------------------------

Transcript co-responses reveal the functional context of guide genes. The most obvious BR-effect is promotion of growth, and the identified associated genes should mirror this BR-function. The associated genes were manually screened and 44 genes with predicted or known functions in growth processes were identified and selected for real-time RT--PCR analysis. The correlated behaviour of these genes in the nasc0271 data matrix is illustrated in [Figure 3](#fig3){ref-type="fig"}.

BR-induced genes were expected to have reduced transcript levels in BR-mutants and increased transcript levels in BR-treated plants. Three sets of experiments were performed: (i) Wild-type, *dwf1--6*, *cbb3* and *cbb2* plants (all C24 background, mutants allelic to the *dim*, *cpd* and *bri1* mutants) ([@b21]) were grown in half-concentrated Murashige and Skoog medium. Plant material was harvested 14 or 19 days after sowing. (ii) Wild-type, *dwf1--6* and *CPD*-antisense plants ([@b27]) were grown in soil. Plant material was harvested 28 days after sowing. (iii) Wild-type and *dwf1--6* plants were grown in half-concentrated Murashige and Skoog medium and either treated with a control solution or 300 nM EBL.

Transcript levels were determined using real-time RT--PCR. Eight-fold change values were established ([Tables 5](#tbl5){ref-type="table"} and [6](#tbl6){ref-type="table"}). Fold change values \>1.0 indicate a positive BR-effect on transcript levels. *C*~T~ values are provided in Table SII (Supplementary Material).

Twenty-three genes showed reduced transcript levels in at least two BR-mutants ([Table 5](#tbl5){ref-type="table"}). These genes include known BR-responsive genes such as *KCS1* and *TIP2.1* (*δ-TIP*) ([@b17]), four further aquaporins \[*TIP1.1* (At2g36830), *PIP1.2* (At2g45960), *TIP2.1* (At3g16240) and *TIP1.2* (At3g26520)\], a *KCS1* homologue (At5g43760), and genes presumably involved in cell wall modifications \[At1g27600, *AGP21* (At1g55330), At2g06850, *AGP9* (At2g14890), At3g05910, At3g24480, At3g28180, At3g57790, *FLA2* (At4g12730), At4g13340 and At4g18670\]. Fold changes of growth-related genes were more pronounced in 14- and 19-day-old plants in comparison to 28-day-old plants, probably due to reduced growth rates in older plants ([Table 5](#tbl5){ref-type="table"}). Six (of 23) genes also displayed higher mRNA levels in BR-treated plants ([Table 5](#tbl5){ref-type="table"}). Three genes displayed stronger expression in BR-mutants or weaker expression upon BR-treatment ([Table 6](#tbl6){ref-type="table"}). Eighteen genes did not exhibit BR-responsive expression or showed variable transcript levels ([Table 6](#tbl6){ref-type="table"}).

Transcript co-responses point to additional BR functions
--------------------------------------------------------

Positive effects of BR on plant growth upon cold stress and salt stress have been reported ([@b28]). The *ERD4* (*EARLY RESPONSIVE TO DEHYDRATION 4*), *ERD6*, *ERD15* and At1g29470 (similar to *ERD3*) genes showed co-responses with *BRI1* and *BAK1* \[Supplementary EXCEL file sheet 1 (301 genes)\]. Genes involved in auxin responses \[*IAA7*, *IAA14*, *IAA16*, *TIR1* homologs (At3g26810 and At4g03190) and *GRH1* (At4g03190)\], auxin transport (*PIN3* and *AUX1*) and ethylene responses (*EIL1*, At3g11930, *ERF7* and *EIN2*) were identified, thus providing further evidence for phytohormone interactions. Expression of the *IAA14* and At3g11930 genes was reported to be weaker in roots of the *dwf1--6* mutant in comparison to roots of wild-type plants ([@b8]). Transcription factors such as *BEE1*, *GTL1* and *MYC1* showed co-responses. These genes are induced upon BR-treatment ([@b6],[@b29]). Co-responses of genes encoding ubiquitin-conjugating enzymes (At1g63800 and At1g64230), the ubiquitin-ligase RMA1 and F-box proteins (At1g30200, At1g67480, At2g18280, At3g06380, At3g61060, At5g27920 and At5g60570) may indicate that BR promotes specific protein degradation and thus modifies signalling pathways.

Interestingly, several genes showing high sequence similarity to BR-signalling components also showed co-responses \[genes similar to *BRI1*: At1g28440, At1g72180, and At2g01950 (BRL2, 35); *BAK1*: At1g07650 and At3g14840; *BRZ1*/*BES1*: At1g78700). These genes could be involved in the mediation of BR-responses.

DISCUSSION
==========

Transcript co-response analyses: a novel approach
-------------------------------------------------

Transcript co-response analysis differs from direct approaches in several ways. Transcript co-response analysis allows ruling out outliers and conditional changes of transcript levels. The genotype, developmental stage, environmental conditions and tissue determine specific expression patterns. Consequently, BR-induced or BR-repressed genes depend on the experimental conditions ([@b6]--[@b12]). The data matrices of CSB.DB combine numerous experiments. Thus, statistically significant transcript co-responses mark robust expression patterns.Transcript co-response analysis describes the functional context of genes and provides insights into networks. The statistical approach allows the identification of pathway-involved genes, but also highlights the functional context of genes.CSB.DB is an open access resource. The proposed strategy can easily be adapted to other biological problems. To demonstrate the value of this approach, we established and used the nasc0271, nasc0272 and nasc0273 data matrices for the identification of BR-related genes.

Direct approaches versus transcript co-response analyses
--------------------------------------------------------

Direct approaches analysed plants with altered BR-levels or impaired BR-sensitivity ([@b6]--[@b12]). However, altered transcript levels in these plants do not necessarily reflect normal physiological events, because physiological networks are disrupted. Expression profiling experiments of BR-mutants might be compromised by secondary effects that arise due to the long-term BR deficiency, resulting in physiological aberrations that in turn cause changes in expression patterns rather unrelated to the primary action of BR. For example, BR-mutants show altered light and stress responses, delayed development, impaired photosynthesis, reduced root systems and reduced fertility.

BR treatment of plants (the status of which is determined by the genotype, developmental stage and environment) results in an artificial status in which established networks are overlaid. The rate of uptake and the degree of distribution of the exogenously applied BR are unknown and thus is the actual dose of BR and the tissues reached. Long-term application of higher concentrations of active BRs results in severe developmental alterations and can be lethal. Consequently, BR-treatments trigger antagonistic events, which are switched off in the presence of physiological BR-levels (i.e. in the experiments used for the nasc0271 matrix). Antagonistic events probably serve to limit responses and counter toxic BR-effects. BR-treatments repress BR-biosynthetic genes such as *CPD* and *DWF4* ([@b30],[@b31]) and BR-signalling genes such as *BRI1*, and induce genes involved in the inactivation of BR such as *BAS1* ([@b7],[@b32]). Thus, BR-repressed genes partly represent components required for BR-action.

Due to conditional disturbances of networks, previous expression profiling approaches identified widely different sets of BR-regulated genes ([@b11],[@b12]). Transcript co-response analysis allows to analyse BR-related genes in plants with intact BR-biosynthesis and BR-signalling pathways. In fact, the analysis of BR-related genes is barely possible in a data matrix based on expression profiles of BR-mutants: BR-mutants do not show BR-dependent expression patterns, correlations of BR-related genes are disrupted. Similarly, correlations of BR-related genes are at least partly disrupted in BR-treated plants because of antagonistic events.

The combination of many different experiments accounts for the fact that only 23 or 22 genes were present in the complex matrices used in this study. It also explains that the *BRI1* and *BAK1* guide genes identified only a subset of these genes. Different context-specific data matrices probably would raise the recovery.

Identification of BR-related genes: BR-regulated genes and the functional context
---------------------------------------------------------------------------------

Our statistical approach was based on a wide range of experiments. A total of 51 expression profiles were included in the nasc0271 matrix. The *BRI1* and *BAK1* genes were selected to screen for BR-related genes. One group of genes was identified which showed positively correlated expression in the nasc0271 matrix \[Supplementary EXCEL file sheet 1 (301 genes)\]. Experimental evaluation using BR-mutants, BR- and BRZ-treated plants divided this group into three subgroups: BR-induced genes \[in total 72 genes (24%)\], BR-repressed genes \[in total 16 genes (5%)\] and genes which were not affected by altered BR-levels or showed variable expression \[213 genes (71%)\]. The identification of BR-repressed genes and the large number of genes which were not affected by BR-treatments appear to contradict BR-induction inferred from positive correlations with *BRI1* and *BAK1*. However, as mentioned above the identification of common expression patterns in correlation matrices constitutes a context analysis.

On one hand, transcript co-response analysis identifies pathway-involved genes, because *BRI1* and *BAK1* are required for BR-responses. The specificity of the guide genes was demonstrated by the finding that the identified genes were virtually unaffected by GA. On the other hand, transcript co-responses provide insights into networks. Gene expression patterns are determined by various factors, and these factors are mirrored in correlations. In theory, the observed transcript co-responses could (also) represent co-responses with such unknown factors. Co-response analyses in different matrices could hold the potential to identify upstream factors which determine *BRI1* and *BAK1* expression.

The functional context comprises physiological pathways, which are (also) regulated by other signalling pathways. Growth-related genes exemplify one aspect of the functional context of the *BRI1* and *BAK1* genes. BR promotes growth in all plant organs at early developmental stages. There is increasing evidence for involvement of several molecular mechanisms such as cell wall loosening, acidification of wall space, carbohydrate allocation, carbon assimilation and control of aquaporin activity ([@b33]). BR apparently coordinates and integrates diverse processes required for growth. Transcript levels of growth-related genes were analysed in BR-mutants and BR- or BRZ-treated plants. A subset of these genes could not be identified as BR-responsive despite the fact that a large set of experiments was performed.

Another example is the identification of auxin-signalling components (e.g. *IAA* genes), which are not BR-responsive. The BR--auxin interaction is an important aspect in growth processes ([@b19],[@b33]). Thus, the transcript co-responses provided additional information about the growth processes in which BR is involved that could not be derived from direct approaches.

Potentials and limitations of transcript co-response analyses
-------------------------------------------------------------

Transcript co-responses can help to learn more about physiological pathways. The results critically depend on the guide genes and the data matrix. Biological knowledge is required for selection of suitable guide genes, and co-responses for a given gene cannot be expected in all data matrices. In this study, the BR-signalling components *BRI1* and *BAK1* were used as guide genes in combination with the complex nasc0271 matrix. However, *BRI1* and *BAK1* may not represent suitable guide genes in other data matrices. For example, *BRI1* or *BAK1* homologs could perform better in tissue or stress-specific matrices.

This implies that specific data matrices are necessary to identify co-responses for genes with context-specific expression. For example, numerous stress-related genes are only expressed under stress. Therefore, co-response analysis with stress-signalling components results in incomplete coverage of target genes in a complex matrix. Tissue-specific matrices hold the potential to analyse expression patterns which are hidden in whole plant profiles.

Statistical approaches have limitations. Correlations do not allow discrimination between primary and secondary events and are not equal to causal relationships. Thus, direct approaches are still necessary for the functional characterization of genes. Other limitations are shared with direct approaches. Reliable measurements of all transcripts are not feasible, and there is an ongoing debate about optimal normalization procedures. In this study, the Affymetrix MAS5.0 and GCOS software were used to normalize the expression profiles. For specific data matrices, alternative normalization procedures will be implemented (e.g. RMA for tissue-specific matrices).

CSB.DB: a valuable public resource to uncover genomic effects
-------------------------------------------------------------

In this study, we focused on genes showing positive transcript co-responses. CSB.DB also allows screening for genes which display negative correlation coefficients. Following the presented approach, 404 genes would have had negative transcript co-responses with both *BRI1* and *BAK1* \[*r*~s~ \< (−0.35), *p*-value \< 0.01 and power \> 0.7\]. Future work shall address the analysis and experimental verification of negative co-responses. We currently construct subsets of expression experiments which will allow screening for co-responses under specific experimental conditions. All data matrices will be publicly available.
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![Strategy of transcript co-response analyses.](gki566f1){#fig1}

![*BRI1* (At4g39400) and *BAK1* (At4g33430) transcript levels denoted as log~2~ signals in 51 expression profiles underlying the nasc0271 data matrix (upper panel). Lines are drawn to aid interpretation. Scatter plot of log~2~ signals (lower panel).](gki566f2){#fig2}

![Transcript levels of 44 cell wall and growth-related genes denoted as log~2~ signals in 51 expression profiles underlying the nasc0271 data matrix. Dots and bars give average log~2~ signals of all genes and SD values, respectively. Lines are drawn to aid interpretation.](gki566f3){#fig3}

###### 

Primers used for real-time RT--PCR analysis

  Gene        Sense primer             Antisense primer         E ± SD
  ----------- ------------------------ ------------------------ ----------------
  At1g01120   ACCGAAGCTAAGGGTCGGGTTA   GTAACTCTTTCCAAACCGCACT   0.838 ± 0.007
  At1g01620   CGGAACCTTCGTCCTTGTCT     ATTGGGAGTGGTGCCAAAAT     0.936 ± 0.007
  At1g03870   GGTGAGATGTTCGGAGAGCA     TGACTTATCCGACGGTGACG     0.862 ± 0.003
  At1g27600   CGACGTCCCTTTTCACATCC     TCCATCTCGCTTTCATCAGC     0.906 ± 0.003
  At1g31310   TGTGGAGGAGGTTGGACGTA     CTCTCCCTAATCGCGTTTGC     0.857 ± 0.005
  At1g55330   CAGCTCCAAGCCCAACTTCT     TGAAACCAGATGCCAAAGCA     0.896 ± 0.049
  At1g70210   ACGAGAGCCCTGAGACTTGG     GGCCATCGCTTTCATCAGTC     0.861 ± 0.012
  At2g06850   CTGAACAATGGCGTCGTCTC     CTGGCATAACCGGGAACCTA     0.894 ± 0.016
  At2g14890   TTGGATCTGTTCTCGTCTGG     TCCCAAGCAATACAGTGGAA     0.936 ± 0.002
  At2g16850   AGAAGTGCCCGTGACTCTCA     CCAAAGCTTCTGGCTGGATT     0.868 ± 0001
  At2g22840   GCGATGCGTGGATCAGATAA     GAAGCCCCTCGAGAATTTTG     0.757 ± 0.011
  At2g36400   TTTTGGTGGTGGTGGTGGTA     TCTTGCTTCATCTCCGAACA     0.833 ± 0.021
  At2g36830   TCGCTTGCCTCATCCTTAAA     TCGAAAACGAAAGCGTTCAA     0.981 ± 0000
  At2g45960   CCAAGAGAAACGCTCGTGAC     CCAGTAATGGGGATGGTTGC     0.898 ± 0.036
  At3g05910   CGGTGGCAATAGCTGTAGGA     CACCAAGTTGTGGCAGCTCT     0.874 ± 0.011
  At3g16240   CACAGTCATCACCGGAGTTT     GATCCTAGTCCAGCCGCAAC     0.934 ± 0.012
  At3g24480   ACCGCCAGTCCATCACAGTT     GTGGTGGGGGAGATGCATAG     0.892 ± 0.018
  At3g26520   GTTTCTGGCCGTTGGATCAT     TTGCACAAAAGCCTTCCAGA     0.991 ± 0.000
  At3g28180   GCAACAACATCGTTGGCATT     CGCCTTCTTCCAAACCGATA     0.907 ± 0.005
  At3g53420   CCACCAATTCGTTCTGAGAG     GTGTTTAGACGTTGGCAGCA     0.887 ± 0.014
  At3g57790   TTACAGTGCAGGGCTTGTGG     AACCCGTTCACATGCTCCAT     0.917 ± 0.014
  At3g61430   GACCATTCCTGGGATGACCA     TGGCTCTGATGACAACCACA     0.953 ± 0.026
  At4g02500   CGGTGTTCGAAGCTGATGAT     GAATCCCCCAGTAACCGTGA     0.952 ± 0.006
  At4g12420   TCGGACACCCTGACAATGTT     CGTGAATCCAATGCTCTTCG     0.854 ± 0.003
  At4g12730   CGTGGCATTTACCTCGCTTT     TTCCAAATCTCCACACCAAG     0.899 ± 0.000
  At4g13340   AGGACCACTACCACCGGTCA     CGATCTGTTCGTGTCACGTC     0.791 ± 0.004
  At4g14130   CTGGAGACCCCAACACATCA     TGGGTTGACTCTTTGGGAAA     0.842 ± 0.013
  At4g18670   GCCGTCGTCACCTAGTCCTC     GGTGGGGATGGAGGAGAGTA     0.724 ± 0.001
  At4g19410   CTTGGTCCGGTGACAAAGGT     ATGCACTCCGGCCATAAAAC     0.704 ± 0.000
  At4g23400   ATTAACCCGGCCAGGAGTCT     GATGGTACAGAGCAGCAAGC     0.917 ± 0.001
  At4g25260   TTGAGCAATTCGCTGAAGGA     GCGGTCTCATCTGTCAGTGC     0.897 ± 0.000
  At4g25620   ACGGGTCGTCAAGGCATAAT     AACCGGAACGGTTTAGCTTG     0.833 ± 0.001
  At4g31590   CGGGACCTATGCAGCTTTTC     TCAGATTCGCCTTCTTCCAT     0.890 ± 0.001
  At5g01210   GGGGAAAACCGTTAGCTGTG     ACTTCCAGATCCACGCTTCC     0.832 ± 0.008
  At5g05170   ATTGCCAGCCGTTTGTCTCT     TATACCCGTGGCGAAAATGG     0.949 ± 0.007
  At5g07830   CAGCTACGGGTTTACGCACA     CCACGTTTATGCCATTGCTG     0.870 ± 0.022
  At5g12250   GGACAATGAAGCCCTTTACG     CCGGGAACCTAAGACAGCAT     0.773 ± 0.042
  At5g19770   TCTCCGTCCGTCGAAGAAGT     GACCTGGATCCCAGCTTGTC     0.884 ± 0.001
  At5g20250   AACTCGCGATTGTTTGTTCG     CACGCCAAGAACTCCAGTGT     0.892 ± 0.016
  At5g26670   GGAGCTGTCACAATCTGGTC     ACGAATGCAGCAAAATGTCA     0.838 ± 0.007
  At5g43760   AATCTTGGTGGAATGGGATG     GCGTATGAGTTTGGTTGCAC     0.872 ± 0.027
  At5g55730   TAATGTCGGCTCATGGATGC     CATTGCATCATCTCCTGGAC     0.986 ± 0.002
  At5g60390   TTGACAGGCGTTCTGGTAAGG    CAGCGTCACCATTCTTCAAAAA   Not determined
  At5g64740   CCCTGCCATCTGTCTTCTCA     AGAAGAGCGCCATGAAGAGG     0.884 ± 0.006
  At5g67260   CCGTATGTTTCTCGATGTGC     ATTGTAGCCGATGGCCGATA     0.822 ± 0.009

The amplification efficiency (*E*) was determined for each primer pair \[see Materials and Methods and ([@b34])\].

###### 

CEL files from AtGenExpress used in this study

  Experiment      Genotype            Experiment                  Baseline
  --------------- ------------------- --------------------------- ---------------------------
  10 nM BL        Wild-type (Col-0)                               
      30 min                          BL30-2 and BL30-3           mock 30-2 and mock 30-3
      1 h                             BL1-2 and BL1-3             mock 1-2 and mock 1-3
      3 h                             BL3-2 and BL3-3             mock 3-2 and mock 3-3
  10 nM BL        det2-1                                          
      30 min                          det2BL30-1 and det2BL30-2   det2m30-1 and det2m30-2
      1 h                             det2BL1-1 and det2BL1-2     det2m1-1 and det2m1-2
      3 h                             det2BL3-1 and det2BL3-2     det2m3-1 and det2m3-2
  1 μM GA3        Wild-type (Col-0)                               
      30 min                          GA3 30-2 and GA3 30-3       mock 30-2 and mock 30-3
      1 h                             GA3 1-2 and GA3 1-3         mock 1-2 and mock 1-3
      3 h                             GA3 3-2 and GA3 3-3         mock 3-2 and mock 3-3
  1 μM GA3        ga1-5                                           
      30 min                          GA1-5G30-1 and GA1-5G30-2   GA1-5m30-1 and GA1-5m30-2
      1 h                             GA1-5G1-1 and GA1-5G1-2     GA1-5m1-1 and GA1-5m1-2
      3 h                             GA1-5G3-1 and GA1-5G3-2     GA1-5m3-1 and GA1-5m3-2
      100 nM CS   det2-1              CS3h-1 and CS3h-2           m3h-1 and m3h-2
  10 μM BRZ220    Wild-type (Col-0)                               
      3 h                             mock 3h-1 and mock 3h-2     2203h-1 and 2203h
      12 h                            mock12h-1 and mock 12h-2    220 12h-1 and 220 12h-2
  10 μM BRZ91     Wild-type (Col-0)                               
      3 h                             mock 3h-1 and mock 3h-2     91 3h-1 and 91 3h-2
      12 h                            mock12h-1 and mock 12h-2    91 12h-1 91 12h-2
  10 μM PAC       Wild-type (Col-0)                               
      3 h                             mock 3h-1 and mock 3h-2     pac 3h-1 and pac 3h-2
      12 h                            mock12h-1 and mock 12h-2    pac 12h-1 and pac 12h-2

###### 

Recovery of known BR-regulated genes by transcript co-response analyses

  Gene              Function       References                                nasc0271          nasc0272   nasc0273                                           
  ----------------- -------------- ----------------------------------------- ----------------- ---------- ---------- ----- ------ ------ ----- ------ ------ -----
  BR-signalling                                                                                                                                              
      At1g19350     BES1           BR-signalling positive regulator          ([@b10])          n.a.                        n.a.                n.a.          
      At1g55610     BRL1           Protein kinase                            ([@b35])          n.a.                        n.a.                n.a.          
      At1g75080     BZR1           BR-signalling positive regulator          ([@b36])          x          0.0        0.0   x      4.5    0.1   x      9.1    0.2
      At3g13380     BRL3           Protein kinase                            ([@b35])          n.a.                        n.a.                n.a.          
      At4g18710     BIN2           Shaggy-like kinase                        ([@b37])          x          30.4       0.6   x      22.7   0.8   x      18.2   0.4
      At4g33430     BAK1           Receptor kinase                           ([@b23],[@b24])   x          47.8       1.5   x      31.8   1.8   x      36.4   1.7
      At4g39400     BRI1           Receptor kinase                           ([@b20])          x          47.8       0.9   x      45.5   1.7   x      45.5   1.0
  BR-biosynthesis                                                                                                                                            
      At3g50660     DWF4           Cytochrome P450 90B1                      ([@b38])          n.a.                        n.a.                n.a.          
      At4g36380     ROT3           Cytochrome P450 90C1                      ([@b39])          n.a.                        n.a.                n.a.          
      At5g05690     CPD            Cytochrome P450 90A1                      ([@b40])          x          43.5       0.7   x      40.9   0.8   x      45.5   0.8
      At5g38970     CYP85A1        Cytochrome P450 85A1                      ([@b41])          n.a.                        n.a.                n.a.          
  BR-upregulated                                                                                                                                             
      At1g01120     KCS1           Fatty acid elongase                       ([@b7],[@b17])    x          45.5       1.0   x      42.9   1.0   x      42.9   1.0
      At1g04240     IAA3/SHY2      Auxin-responsive protein                  ([@b6],[@b7])     x          36.4       0.8   x      33.3   0.6   x      33.3   0.7
      At1g04610     YUCCA 3        Flavin-containing monooxygenase           ([@b10])          n.a.                        n.a.                n.a.          
      At1g15580     IAA5           Auxin-responsive protein                  ([@b7],[@b9])     n.a.                        n.a.                n.a.          
      At1g18400     BEE1           Basic helix--loop--helix family protein   ([@b19],[@b29])   x          40.9       0.8   x      38.1   0.7   x      42.9   0.9
      At1g20440     COR47          Dehydrin                                  ([@b6])           x          4.5        0.3   x      28.6   1.3   x      33.3   1.9
      At1g21820                    Unknown protein                           ([@b10],[@b19])   x          54.5       1.0   x      42.9   0.9   x      28.6   0.7
      At1g33240     GTL1           Plant transcriptional activator           ([@b6],[@b19])    x          54.5       1.2   x      38.1   0.8   x      33.3   0.9
      At1g65310                    Xyloglucan endotransglycosylase           ([@b7],[@b19])    n.a.                        n.a.                n.a.          
      At1g67730     GLOSSY8        Putative β-keto acyl reductase            ([@b6])           x          40.9       0.8   x      23.8   0.6   x      23.8   0.6
      At1g73830     BEE3           Basic helix--loop--helix family protein   ([@b19],[@b29])   n.a.                        n.a.                n.a.          
      At1g76680     OPR1           12-Oxophytodienoate reductase             ([@b7],[@b9])     n.a.                        n.a.                n.a.          
      At2g14900                    Unknown protein                           ([@b10],[@b19])   n.a.                        n.a.                n.a.          
      At2g26710     BAS1/CYP72B1   Cytochrome P450                           ([@b7],[@b19])    n.a.                        n.a.                n.a.          
      At2g27690     CYP94C1        Cytochrome P450                           ([@b7],[@b19])    n.a.                        n.a.                n.a.          
      At2g31730                    Unknown protein                           ([@b7],[@b19])    n.a.                        n.a.                n.a.          
      At2g32560                    F-box family protein                      ([@b10],[@b19])   x          4.5        0.1   x      0      0     x      4.8    0.1
      At2g36220                    Unknown protein                           ([@b9],[@b19])    n.a.                        n.a.                n.a.          
      At2g40610     EXP8           Expansin                                  ([@b7],[@b10])    n.a.                        n.a.                n.a.          
      At2g41940     ZFP8           Zinc finger protein                       ([@b6],[@b19])    n.a.                        n.a.                n.a.          
      At2g43290     MSS3           Calmodulin-like protein                   ([@b7],[@b19])    x          22.7       0.4   x      14.3   0.3   x      14.3   0.3
      At3g12610     DRT100         DNA-damage-repair/toleration protein      ([@b19])          x          59.1       1.2   x      42.9   0.9   x      42.9   1.1
      At3g15540     IAA19          Auxin-responsive protein                  ([@b6],[@b7])     n.a.                        n.a.                n.a.          
      At3g16240     TIP2.1/d-TIP   Aquaporin                                 ([@b6],[@b17])    x          63.6       1.5   x      52.4   1.3   x      52.4   1.6
      At3g29030     EXP5           Expansin                                  ([@b6],[@b19])    n.a.                        n.a.                n.a.          
      At3g30775     ERD5/PRO1      Proline oxidase                           ([@b6],[@b19])    x          50.0       1.1   x      42.9   1.3   x      33.3   0.8
      At3g46090     ZAT7           Zinc finger protein                       ([@b7],[@b9])     n.a.                        n.a.                n.a.          
      At3g47340     ASN1           Asparagine synthetase                     ([@b6])           x          40.9       1.0   x      28.6   0.7   x      33.3   1.0
      At4g00360     CYP86A2        Cytochrome P450                           ([@b7],[@b19])    n.a.                        n.a.                n.a.          
      At4g01950                    Phospholipid/glycerol acyltransferase     ([@b10],[@b19])   n.a.                        n.a.                n.a.          
      At4g08950     EXO            Transcriptional regulator                 ([@b7],[@b17])    x          40.9       0.8   n.a.                n.a.          
      At4g09460     MYB6           myb Family transcription factor           ([@b6],[@b19])    x          54.5       0.9   x      52.4   1.3   x      52.4   1.3
      At4g09890                    Unknown protein                           ([@b9],[@b19])    x          18.2       0.7   x      4.8    0.1   x      0.0    0.0
      At4g20780                    Calcium-binding protein                   ([@b10],[@b19])   x          4.5        0.3   x      4.8    0.1   x      0.0    0.0
      At4g25810     XTR6           Xyloglucan endotransglycosylase           ([@b7],[@b19])    n.a.                        n.a.                n.a.          
      At4g34160     CYCD3          Cyclin                                    ([@b42])          x          22.7       0.5   x      9.5    0.4   x      0.0    0.0
      At4g36540     BEE2           Basic helix--loop--helix family protein   ([@b29])          n.a.                        n.a.                n.a.          
      At4g37390     GH3-2/YDK1     Auxin-responsive protein                  ([@b7],[@b9])     n.a.                        n.a.                n.a.          
      At4g38850     SAUR-AC1       Auxin-responsive protein                  ([@b7],[@b19])    n.a.                        n.a.                n.a.          
      At4g38860     SAUR16         Auxin-responsive protein                  ([@b7],[@b19])    n.a.                        n.a.                n.a.          
      At5g04190                    Phytochrome kinase substrate-related      ([@b19])          n.a.                        n.a.                n.a.          
      At5g06720     ATPA2          Peroxidase                                ([@b7],[@b19])    x          9.1        0.3   x      4.8    0.1   x      0.0    0.0
      At5g10430     AGP4           Arabinogalactan-protein                   ([@b6],[@b7])     x          45.5       1.0   x      47.6   1.0   x      38.1   1.0
      At5g13870     EXGT-A4        Xyloglucan endotransglycosylase           ([@b10])          n.a.                        n.a.                n.a.          
      At5g37770     TCH2           Calmodulin-related protein                ([@b7],[@b19])    x          18.2       0.4   x      14.3   0.4   x      9.5    0.2
      At5g47370     HAT2           Homeobox-leucine zipper protein           ([@b6])           x          36.4       0.9   x      23.8   0.6   x      9.5    0.2
      At5g51460     TPPA           Trehalose-6-phosphate phosphatase         ([@b6])           n.a.                        n.a.                n.a.          
      At5g57560     TCH4           Xyloglucan endotransglycosylase           ([@b6],[@b43])    x          40.9       0.8   x      28.6   0.6   x      23.8   0.6
      At5g64000     SAL2           3′(2′),5′-Bisphosphate nucleotidase       ([@b6])           n.a.                        n.a.                n.a.          
      At5g66400     RAB18          Dehydrin                                  ([@b6])           n.a.                        n.a.                n.a.          

In the nasc0271, nasc0272 and nasc0273 matrices, 23, 22 and 22 published BR-regulated genes were present, respectively. BR-signalling genes, BR-biosynthesis genes and BR-regulated genes were used for co-response analyses. BR-regulated genes were termed 'recovered' in case significant correlations that were calculated (criteria as mentioned in the text). '%rec' gives the percentage of the known BR-regulated genes (present in the respective matrix) identified by transcript co-response analysis; '%spec' gives the percentage of identified known BR-regulated genes relating to the total number of genes showing significant co-responses. Underlying data are provided as Supplementary Material \[supplement.XLS sheet 8 (nasc0271)\], sheet 9 (nasc0272) and sheet 10 (nasc0273)\]. 'n.a.': Gene not analysable. 'x': Gene present in data matrix.

###### 

Intersection gene queries with BR-signalling components

  Gene combination            Recovery      Maximum   %recovery   Intersection   %specificity   
  --------------------------- ------------- --------- ----------- -------------- -------------- -----
  nasc271                                                                                       
      At4g39400 + At4g33430   BRI1 + BAK1   8         23          34.8           301            2.7
      At4g39400 + At4g18710   BRI1 + BIN2   3         23          13.0           227            1.3
      At4g39400 + At1g75080   BRI1 + BZR1   0         23          0.0            109            0.0
      At4g33430 + At4g18710   BAK1 + BIN2   3         23          13.0           234            1.3
      At4g33430 + At1g75080   BAK1 + BZR1   0         23          0.0            1              0.0
      At4g18710 + At1g75080   BIN2 + BZR1   0         23          0.0            18             0.0
  nasc0272                                                                                      
      At4g39400 + At4g33430   BRI1 + BAK1   4         22          18.2           144            2.8
      At4g39400 + At4g18710   BRI1 + BIN2   1         22          4.5            184            0.5
      At4g39400 + At1g75080   BRI1 + BZR1   0         22          0.0            373            0.0
      At4g33430 + At4g18710   BAK1 + BIN2   3         22          13.6           301            1.0
      At4g33430 + At1g75080   BAK1 + BZR1   0         22          0.0            6              0.0
      At4g18710 + At1g75080   BIN2 + BZR1   0         22          0.0            4              0.0
  nasc0273                                                                                      
      At4g39400 + At4g33430   BRI1 + BAK1   5         22          22.7           161            3.1
      At4g39400 + At4g18710   BRI1 + BIN2   1         22          4.5            194            0.5
      At4g39400 + At1g75080   BRI1 + BZR1   0         22          0.0            229            0.0
      At4g33430 + At4g18710   BAK1 + BIN2   3         22          13.6           231            1.3
      At4g33430 + At1g75080   BAK1 + BZR1   0         22          0.0            3              0.0
      At4g18710 + At1g75080   BIN2 + BZR1   0         22          0.0            3              0.0

Recovery of known BR-regulated genes ([Table 3](#tbl3){ref-type="table"}) was tested in intersection gene queries of 2 signalling components. Intersections of BR-biosynthesis genes could not be tested because only the *CPD* gene was present in the matrices ([Table 3](#tbl3){ref-type="table"}). 'recovery' gives the number of BR-regulated genes identified by means of the respective intersection gene query; 'maximum' gives the number of BR-regulated genes present in the matrix (see [Table 3](#tbl3){ref-type="table"}); '%recovery' gives the percentage of BR-regulated genes identified in the query; 'intersection' gives the number of genes showing significant co-responses with both genes; '%specificity' gives the percentage of BR-regulated genes in the intersection.

###### 

Real-time RT--PCR analysis of cell wall and growth-related genes

  Gene                                                                                 Function    Sterile culture                             Sterile culture   Soil                                 
  ------------------------------------------------------------------------------------ ----------- ------------------------------------------- ----------------- ------ ----- ----- ----- ----- ----- -----
  Weaker expression in at least two mutants, stronger expression upon BR-application                                                                                                                  
      *KCS1*                                                                           At1g01120   Fatty acid elongase                         1.7               1.5    2.2   1.1   1.6   1.4   3.1   1.6
                                                                                       At1g27600   Glycosyltransferase                         2.0               0.9    1.6   1.9   2.3   1.4   1.4   2.0
                                                                                       At3g24480   Leucine-rich repeat extensin                1.4               1.6    1.7   1.4   2.5   1.8   1.6   1.3
      *CSLC4*                                                                          At3g28180   Cellulose synthase                          1.4               0.9    1.9   2.5   1.5   3.0   0.8   1.1
                                                                                       At3g57790   Polygalacturonase/pectinase                 1.3               1.5    1.5   7.3   2.1   3.9   2.6   1.8
                                                                                       At4g13340   Leucine-rich repeat extensin                1.6               1.1    2.9   1.2   1.7   1.9   0.8   1.7
  Weaker expression in at least two mutants                                                                                                                                                           
      *PIP1.3*                                                                         At1g01620   Aquaporin                                   3.7               1.4    1.8   2.5   0.9   1.6   0.9   0.8
      *AGP21*                                                                          At1g55330   Arabinogalactan-protein                     2.1               3.7    4.1   1.9   1.0   1.7   1.2   2.3
      *EXT*                                                                            At2g06850   Xyloglucan endotransglycosylase             2.5               1.3    2.0   1.6   1.2   1.2   1.0   0.8
      *AGP9*                                                                           At2g14890   Arabinogalactan-protein                     1.8               1.9    1.7   1.6   0.7   1.0   1.2   2.0
      *PIP2.8*                                                                         At2g16850   Aquaporin                                   3.6               2.3    3.7   2.5   0.8   1.5   0.8   1.2
      *TIP1.1*                                                                         At2g36830   Aquaporin                                   1.4               1.6    1.2   1.7   0.7   1.2   0.7   1.2
      *PIP1.2*                                                                         At2g45960   Aquaporin                                   1.9               1.8    1.8   1.8   0.7   1.0   1.5   1.0
                                                                                       At3g05910   Pectinacetylesterase                        1.2               1.2    1.5   1.6   1.1   1.6   1.7   1.4
      *TIP2.1*                                                                         At3g16240   Aquaporin                                   2.8               1.5    2.3   1.9   0.9   1.3   0.8   1.0
      *TIP1.2*                                                                         At3g26520   Aquaporin                                   1.6               2.2    1.7   1.8   1.5   1.2   1.4   1.8
      *PIP2.1*                                                                         At3g53420   Aquaporin                                   2.6               1.4    1.9   1.5   0.7   0.6   1.7   1.0
      *PIP1.1*                                                                         At3g61430   Aquaporin                                   2.7               1.5    1.7   1.9   0.9   1.0   1.6   1.1
      *SKU5*                                                                           At4g12420   Pectinesterase                              1.4               1.3    2.0   1.0   1.1   1.0   0.8   0.9
      *FLA2*                                                                           At4g12730   Fasciclin-like arabinogalactan-protein      1.5               2.5    2.7   0.8   1.2   1.0   1.3   1.7
                                                                                       At4g18670   Leucine-rich repeat extensin                1.1               1.5    2.1   1.4   0.8   1.0   1.0   1.2
                                                                                       At4g25260   Invertase/pectin methylesterase inhibitor   1.3               1.9    1.1   1.3   0.7   0.9   1.0   1.9
                                                                                       At5g43760   β-Ketoacyl-CoA synthase                     1.8               1.6    1.7   1.3   0.9   1.0   0.8   0.7

Wild-type plants and different BR mutants were grown under aseptic conditions (columns 1--6) or in soil (columns 7 and 8) and harvested after 14 days (column 1), 19 days (columns 2--6) and 28 days (columns 7 and 8), respectively. Plant material was treated with a control solution or 300 nM 24-epibrassinolide and harvested 5 h after treatment (columns 5 and 6). Control treatments were also used to compare basal transcript levels in wild-type and *dwf1-6* plants (column 4). Fold change ratios were calculated taking into account the amplification efficiencies of primers ([Table 1](#tbl1){ref-type="table"}). RT--PCR data (i.e. *C*~T~ values) are given in Table SII (Supplementary Material).

###### 

Real-time RT--PCR analysis of cell wall- and growth-related genes

  Gene                                                                      Function    Sterile culture                          Sterile culture   Soil                                 
  ------------------------------------------------------------------------- ----------- ---------------------------------------- ----------------- ------ ----- ----- ----- ----- ----- -----
  No consistent BR-dependent or variable expression                                                                                                                                     
      *FLA9*                                                                At1g03870   Fasciclin-like arabinogalactan-protein   1.6               1.1    0.8   1.0   1.5   1.5   1.1   1.0
                                                                            At1g31310   Hydroxyproline-rich glycoprotein         0.9               0.5    0.6   1.1   1.8   1.1   0.6   1.0
      *CYCD1.1*                                                             At1g70210   Cyclin                                   2.3               0.8    1.2   2.8   0.4   0.8   0.9   1.0
                                                                            At4g02500   Galactosyl transferase                   1.1               1.0    1.1   0.8   0.8   1.1   1.2   0.8
                                                                            At4g19410   Pectinacetylesterase                     1.1               0.9    1.1   1.1   2.3   1.1   1.0   1.5
      *PIP1.5*                                                              At4g23400   aquaporin                                2.0               1.7    1.4   1.3   0.7   0.5   0.7   0.7
                                                                            At4g25620   Hydroxyproline-rich glycoprotein         1.0               0.7    1.1   1.0   1.1   0.8   0.6   0.6
      *CSLC5*                                                               At4g31590   Cellulose synthase                       1.2               1.0    1.5   1.8   0.5   0.7   1.5   1.0
                                                                            At5g01210   Transferase                              1.0               1.1    1.0   0.5   1.1   0.7   1.1   0.9
      *CESA3*                                                               At5g05170   Cellulose synthase                       1.4               1.0    1.3   1.1   1.0   1.0   1.3   1.2
                                                                            At5g07830   Glycosyl hydrolase                       0.8               1.0    1.2   1.0   1.0   1.4   1.8   1.4
      *TUB6*                                                                At5g12250   Tubulin                                  1.2               1.2    1.4   1.3   0.9   1.0   1.5   1.7
      *TUA3*                                                                At5g19770   Tubulin                                  1.2               1.3    1.1   1.3   0.6   1.1   1.5   1.8
      *DIN10*                                                               At5g20250   Glycosyl hydrolase                       1.7               1.4    2.2   0.5   2.3   1.3   0.4   1.4
                                                                            At5g26670   Pectinacetylesterase                     1.0               0.8    1.3   1.5   0.8   0.8   1.2   1.2
      *FLA1*                                                                At5g55730   Fasciclin-like arabinogalactan-protein   1.0               1.2    1.0   0.8   1.1   0.6   1.3   1.8
      *CESA6*                                                               At5g64740   Cellulose synthase                       1.2               1.1    1.8   1.4   1.0   1.2   1.2   0.7
      *CYCD3.2*                                                             At5g67260   Cyclin                                   1.5               1.0    1.1   1.7   0.5   0.7   0.7   1.0
  Stronger expression in mutants or weaker expression upon BR-application                                                                                                               
      *GRL1*                                                                At2g22840   Transcription activator                  1.2               1.1    1.6   1.4   0.5   0.7   0.6   0.6
      *GRL3*                                                                At2g36400   Transcription activator                  1.2               1.0    1.3   1.2   0.6   0.6   0.4   0.5
      *XTR7*                                                                At4g14130   Xyloglucan endotransglycosylase          0.4               0.4    1.1   0.2   3.8   0.3   0.1   0.6

Details given in legend of [Table 5](#tbl5){ref-type="table"}.

[^1]: The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
